Comparative patch clamp studies on the kinetics and selectivity of glutamate receptor antagonism by 2,3-dihydroxy-6-nitro-7-sulfamoyl-benzo(F)quinoxaline (NBQX) and 1-(4-amino-phenyl)-4-methyl-7,8-methylendioxyl-5H-2,3-benzodiazepine (GYKI 52466)

This publication has 55 references indexed in Scilit:

• Effect of glutamate receptor antagonists on N-methyl-D-aspartate- and (S)-α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid-induced convulsant effects in mice and rats
  European Journal of Pharmacology, 1993
• The AMPA antagonist, NBQX, protects against ischemia-induced loss of cerebellar Purkinje cells
  NeuroReport, 1992
• Protection against ischemic hippocampal CAI damage in the rat with a new non-NMDA antagonist, NBQX
  Acta Neurologica Scandinavica, 1992
• Blockade of the AMPA receptor prevents CA1 hippocampal injury following severe but transient forebrain ischemia in adult rats
  Neuroscience Letters, 1991
• Structure‐activity analysis of binding kinetics for NMDA receptor competitive antagonists: the influence of conformational restriction
  British Journal of Pharmacology, 1991
• Delayed AMPA receptor blockade reduces cerebral infarction induced by focal ischemia
  NeuroReport, 1991
• The anticonvulsant effect of the non-NMDA antagonists, NBQX and GYKI 52466, in mice
  Epilepsy Research, 1991
• Effects of antagonists on quisqualate and nicotinic receptor-mediated currents of midbrain neurones in culture
  British Journal of Pharmacology, 1991
• The non-NMDA receptors: types, protein structure and molecular biology
  Trends in Pharmacological Sciences, 1990
• On concanavalin A-treated striatal neurons quisqualate clearly behaves as a partial agonist of a receptor fully activated by kainate
  European Journal of Pharmacology: Molecular Pharmacology, 1990